Riverbank Capital Securities

investment firm

Riverbank Capital Securities is a New York-based venture capital firm specialized in early and late stage venture investments.

Number of Investments

Number of Lead Investments

Riverbank Capital Securities has made 3 investments. Their most recent investment was on Mar 9, 2011, when Kite Pharma raised $15M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Mar 9, 2011 Kite Pharma	Series A	$15M	Biotechnology	—
Sep 28, 2010 Tigris Pharmaceuticals	Series C	$6.50M	Biotechnology	—
Jan 17, 2007 Tigris Pharmaceuticals	Series B	$16M	Biotechnology	—

Number of Employee Profiles

Riverbank Capital Securities has 1 current employee profiles, including Executive Paul Gorman

Executive

Riverbank Capital Securities has had 1 exits. Riverbank Capital Securities most notable exits include Kite Pharma

Date	Company Name	Exit Type	Industry
Jun 27, 2014	Kite Pharma	M&A	Biotechnology	Detail